Skip to main content
Clinical Trials/CTRI/2019/06/019629
CTRI/2019/06/019629
Not yet recruiting
未知

eutrophil-lymphocyte ratio (NLR) and platelet lymphocyte ratio (PLR) as predictive markers for chronic kidney disease in persons with type 2 diabetes

Dr Vignesh Kumar0 sites0 target enrollmentTBD

Overview

Phase
未知
Intervention
Not specified
Conditions
Not specified
Sponsor
Dr Vignesh Kumar
Status
Not yet recruiting
Last Updated
4 years ago

Overview

Brief Summary

No summary available.

Registry
who.int
Start Date
TBD
End Date
TBD
Last Updated
4 years ago
Study Type
Observational

Investigators

Sponsor
Dr Vignesh Kumar

Eligibility Criteria

Inclusion Criteria

  • 1\. Persons with type 2 diabetes without nephropathy or other complications
  • 2\. Persons with type 2 diabetes with CKD

Exclusion Criteria

  • 1\. Patients having low glomerular filtration rate (GFR) without microalbuminuria will be excluded from the study.
  • 2\. Patients with type 1 DM
  • 3\. Febrile patients/patients with infections including urinary tract infection (UTI), respiratory tract infections, gastrointestinal infection, otitis media, viral hepatitis, parasitic infection, viral infection, tuberculosis, local infection, skin infection, AIDS, pyrexia of unknown origin, and any other infectious disease.
  • 4\. Patients with systemic disorder such as cardiovascular disease, chronic liver disease, blood disorders, autoimmune disorders, malignancy, poisoning;
  • 5\. Patients on anti\-inflammatory drugs, systemic or topical steroids, alcohol;
  • 6\. Patients with uncontrolled blood pressure (BP);
  • 7\. Patients having diseases affecting urinary protein excretion as nephritic syndrome, urolithiasis, renal insufficiency, renal artery stenosis, dehydration state, and UTI

Outcomes

Primary Outcomes

Not specified

Similar Trials